Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRB | P28702 | 5/20 | 0.36 |
| ▸ | RXRA | P19793 | 4/20 | 0.33 |
| ▸ | RXRG | P48443 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27952594 | 0.94 | RXRB (0.36) | RXRBRXRARXRGPOLBKDM4E | |
| SCHEMBL27663765 | 0.85 | TSHR (0.36) | POLBKDM4E | |
| SCHEMBL15810239 | 0.82 | TDO2 (0.33) | RXRB | |
| SCHEMBL1241864 | 0.76 | RXRB (0.36) | RXRBRXRARXRGKDM4EGAA | |
| SCHEMBL21381466 | 0.76 | TSHR (0.40) | POLBKDM4E | |
| SCHEMBL28860851 | 0.75 | RXRB (0.35) | RXRBRXRARXRG | |
| SCHEMBL28198733 | 0.75 | RXRB (0.35) | RXRBRXRARXRG | |
| SCHEMBL14645582 | 0.73 | KDM4E (0.33) | RXRBRXRARXRGPOLBKDM4E | |
| SCHEMBL14645947 | 0.72 | RXRB (0.34) | RXRBRXRARXRGPOLB | |
| SCHEMBL19644561 | 0.72 | RXRA (0.33) | RXRBRXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3131935-B1 | NEW CATALYST SYSTEM FOR PRODUCING POLYETHYLENE COPOLYMERS IN A HIGH TEMPERATURE SOLUTION POLYMERIZATION PROCESS | BOREALIS AG (AT) | 2020-06-03 | — | — | EP | disclosed |
| US-10301411-B2 | Catalyst system for producing polyethylene copolymers in a high temperature solution polymerization process | BOREALIS AG (AT) | 2019-05-28 | — | — | US | disclosed |
| EP-2746301-B1 | Catalyst | BOREALIS AG (AT) | 2018-05-30 | — | — | EP | disclosed |
| EP-2729479-B1 | CATALYSTS | BOREALIS AG (AT) | 2017-09-06 | — | — | EP | disclosed |
| US-9630980-B2 | Asymmetrical ligands | BOREALIS AG (AT) | 2017-04-25 | — | — | US | disclosed |
| US-9598517-B2 | Catalysts | BOREALIS AG (AT) | 2017-03-21 | — | — | US | disclosed |
| US-20170037164-A1 | NEW CATALYST SYSTEM FOR PRODUCING POLYETHYLENE COPOLYMERS IN A HIGH TEMPERATURE SOLUTION POLYMERIZATION PROCESS | BOREALIS AG (AT) | 2017-02-09 | — | — | US | disclosed |
| CN-105377915-A | Process for the preparation of propylene copolymer containing higher alpha-olefins | BOREALIS AG | 2016-03-02 | — | — | CN | disclosed |
| US-20160024123-A1 | Asymmetrical Ligands | BOREALIS AG (AT) | 2016-01-28 | — | — | US | disclosed |
| US-20150344596-A1 | CATALYSTS | BOREALIS AG (AT) | 2015-12-03 | — | — | US | disclosed |
| US-9187583-B2 | Catalysts | BOREALIS AG (AT) | 2015-11-17 | — | — | US | disclosed |
| EP-2933277-A1 | New catalyst system for producing polyethylene copolymers in a high temperature solution polymerization process | Borealis AG (AT) | 2015-10-21 | — | — | EP | disclosed |
| US-20140221584-A1 | CATALYSTS | BOREALIS AG (AT) | 2014-08-07 | — | — | US | disclosed |
| WO-2014096166-A1 | CATALYSTS | BOREALIS AG (AT) | 2014-06-26 | — | — | WO | disclosed |
| EP-2746301-A1 | Catalyst | Borealis AG (AT) | 2014-06-25 | — | — | EP | disclosed |
| EP-2729479-A1 | CATALYSTS | Borealis AG (AT) | 2014-05-14 | — | — | EP | disclosed |
| CN-103649101-A | Catalyst and process for preparing same | BOREALIS AG | 2014-03-19 | — | — | CN | disclosed |
| WO-2013007650-A1 | CATALYSTS | BOREALIS AG (AT) | 2013-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10301411-B2 | Catalyst system for producing polyethylene copolymers in a high temperature solution polymerization process | RPS8, MLX, HRH2 | RXRB 2801/4885RXRA 2019/4885RXRG 2501/4885 |
| US-20170037164-A1 | NEW CATALYST SYSTEM FOR PRODUCING POLYETHYLENE COPOLYMERS IN A HIGH TEMPERATURE SOLUTION POLYMERIZATION PROCESS | RPS8, HRH2, MLX | RXRB 2843/4885RXRA 2033/4885RXRG 2730/4885 |
| US-20160024123-A1 | Asymmetrical Ligands | CCRL2, AR, CCR2 | RXRB 599/4885RXRA 672/4885RXRG 482/4885 |
| US-20150344596-A1 | CATALYSTS | SFN, AP3S1, H1-2 | RXRB 585/4885RXRA 672/4885RXRG 473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.